1 Barts Experimental Cancer Medicine Centre, Barts Cancer Institute, Queen Mary University of London, London, UK. t.powles@qmul.ac.uk.
2 HistogeneX N.V, Wilrijk, Belgium.
3 Department of Medical Oncology, Hospital del Mar, Barcelona, Spain.
4 Instituto de Biomedicina de Sevilla, IBiS, Hospital Universitario Virgen del Rocio, CSIC and Universidad de Sevilla, Seville, Spain.
5 Southampton Experimental Cancer Medicine Centre, University of Southampton, Southampton, UK.
6 Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
7 Barts Experimental Cancer Medicine Centre, Barts Cancer Institute, Queen Mary University of London, London, UK.
8 Catalan Institute of Oncology, Badalona Applied Research Group in Oncology (B.ARGO)-IGTP, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.
9 Institut Paoli-Calmettes, Marseille, France.
10 Department of Medical Oncology, Hospital Clinico Universitario de Santiago, Santiago de Compostela, Spain.
11 Department of Medical Oncology, Churchill Hospital, Oxford, UK.
12 Department of Medical Oncology, Hopital Saint-Andre, University of Bordeaux-CHU Bordeaux, Bordeaux, France.
13 Department of Medical Oncology, Hospital Lyon Sud, Lyon, France.
14 Department of Medical Oncology, Reina Sofia University Hospital, Cordoba, Spain.
15 Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Universitat Autonoma de Barcelona, Barcelona, Spain.
16 Department of Medical Oncology, University College London Hospital, London, UK.
17 Medical Biochemistry, Faculty of Pharmaceutical, Biomedical and Veterinary Sciences, University of Antwerp, Antwerp, Belgium.
18 Genentech, San Francisco, CA, USA.
19 Department of Medical Oncology, Hospital 12 de Octubre, Madrid, Spain.